首页|舌下腺瓣修复临床Ⅱ期慢性黄磷性颌骨骨髓炎和药物相关性颌骨坏死术后缺损

舌下腺瓣修复临床Ⅱ期慢性黄磷性颌骨骨髓炎和药物相关性颌骨坏死术后缺损

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
目的:探讨利用舌下腺瓣修复临床Ⅱ期慢性黄磷性颌骨骨髓炎(PNJ)和药物相关性颌骨坏死(MRONJ)术后颌骨缺损的临床效果.方法:利用舌下腺瓣修复慢性下颌骨坏死术后颌骨缺损的5例患者.其中慢性黄磷性颌骨骨髓炎3例,药物相关性颌骨坏死患者2例.结果:5例患者临床检查评价治疗效果,术后2周内创口愈合良好,无感染,舌下腺功能正常.结论:利用舌下腺瓣修复慢性黄磷性颌骨骨髓炎和药物相关性颌骨坏死术后下颌骨缺损有效可行.
Repair of postoperative defects in chronic phase Ⅱ phosphorous osteomyelitis and medication-related os-teonecrosis of the mandible by sublingual gland flap
Objective:To investigate the clinical outcomes of sublingual gland flap in the repair of postoperative jaw defects because of chronic phosphorous osteomyelitis(PNJ)and medication-related osteonecrosis of the jaw(MRONT).Methods:3 patients with PNJ and 2 with MRONJ were treated by sublingual gland flap in the repair of the postoperative jaw defet.The treatment effects were evalua-ted by clinical obseration.Results:In the 5 patients the wound healed well within 2 weeks postoperatively,with no infection and with normal sublingual gland function after surgery.Conclusion:The use of sublingual gland flap is an effective and feasible method for re-pairing local defects in the mandibles after surgery for chronic PNJ and MRONJ.

Chronic phosphorous osteomyelitis of the jawMedication-related osteonecrosis of the jawPartial mandibular defectSublingual gland flap

谢荣举、王卫红、许彪、朱瑾、钱叶梅、李静宜、张洪荣

展开 >

650106,昆明医科大学附属口腔医院口腔颌面外科

黄磷性颌骨骨髓炎 药物相关性颌骨坏死 下颌骨部分缺损 舌下腺瓣

云南省卫生健康委医学领军人才项目云南省创新团队项目

L-201801202105AE160004

2024

10.3969/j.issn.1001-3733.2024.03.017

实用口腔医学杂志
第四军医大学口腔医学院

实用口腔医学杂志

CSTPCD北大核心
影响因子：0.942
ISSN：1001-3733
年,卷(期)：2024.40(3)
  • 30